Stock CSMED CS MEDICA A/S
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases CS MEDICA A/S

Equities

CSMED

DK0061668225

End-of-day quote NORDIC GROWTH MARKET
Other stock markets
 23:00:00 13/05/2024 BST 		5-day change 1st Jan Change
6.84 DKK -2.88% Intraday chart for CS MEDICA A/S +10.56% +46.06%
04-30 CS Medica A/S Enters New Partnership with OTC Company Holding A Strong Position in the Chronic Pain Segment in Germany CI
04-22 CS Medica A/S Advances Global Reach with 180° Drug Store Alliance, Powered by Pull Market Strategy CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
CS MEDICA Aligns Financial Priorities: Transition to Calendar Year 2024 Postponed
AQ
CS MEDICA A/S Enters New Partnership with Award-Winning OTC Company Holding a Strong Position in the Chronic Pain Segment in Germany
AQ
CS MEDICA A/S: CEO, Lone Henriksen, buys shares in the Company
AQ
CS MEDICA Advances Global Reach with 180˚ Drug Store Alliance, Powered by Pull Market Strategy.
AQ
CS MEDICA A/S Breaks Through Asian Market Barrier with Approval of Protective Nasal Gel in Malaysia
AQ
CS MEDICA Update: Rescheduled Q4 2023 Presentation
AQ
Correction:CS MEDICA A/S: Publication of 2023 Q report
AQ
CS MEDICA A/S: Release of 2023 Q report, for the period October - December 2023, including an invitation to a live-streamed conference call on 5st April, at 11 AM CET.
AQ
CS MEDICA A/S: Minutes of the General Assembly
AQ
Letter from the CEO: CS MEDICA's 2024 Progress Report
AQ
CS MEDICA A/S Partners with New Distributor to Launch CANNASEN® into Jordan
AQ
CS MEDICA A/S: Notice of Shareholders' Annual General Meeting
AQ
CS MEDICA A/S: Publication of Annual Report 2022/2023
AQ
CS MEDICA A/S Achieves New Milestone with Patent on their Wound Care Treatment.
AQ
CS MEDICA Breaks New Ground in Australia with Registration of CANNASEN® Pain Patch and Launch of its Cosmetic Products.
AQ
Danske Bank Extends CS MEDICA's Credit Line
AQ
CS MEDICA A/S Announces FDA authorization for commercialization for Eight Products in the U.S. Market
AQ
CS MEDICA A/S presents the CEO Letter of December 2023
AQ
CS MEDICA postpones its Annual Report to February 24, 2024 and the Annual General Meeting to February 29, 2024
AQ
CS MEDICA A/S: Release of 2022/2023 Q4 report, for the period July - September 2023, including an invitation to a live-streamed conference call on 5st December, at 11 AM CET.
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CSMED Stock
  4. News CS MEDICA A/S
  5. Press Releases